SEC Form 4 · accession 0001127602-15-010397

TEAM HEALTH HOLDINGS INC. · TMH

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

H. Lynn Massingale

Officer — Executive Chairman · Director

Period of report

Mar 4, 2015

Accepted (ET)

Mar 6, 2015 · 10:40 am EST

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001082754

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock^F1,F2	Mar 4, 2015	M	42,442	$14.93	A	156,078	I	See Footnote
Common Stock^F3,F4,F2	Mar 4, 2015	S	42,442	$60.0442	D	113,636	I	See Footnote
Common Stock^F1,F2	Mar 5, 2015	M	19,431	$14.93	A	133,067	I	See Footnote
Common Stock^F3,F5,F2	Mar 5, 2015	S	19,431	$58.6921	D	113,636	I	See Footnote
Common Stock^F1,F2	Mar 5, 2015	M	22,500	$21.64	A	136,136	I	See Footnote
Common Stock^F3,F5,F2	Mar 5, 2015	S	22,500	$58.6921	D	113,636	I	See Footnote

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Options (Right to Buy)^F6,F7	$14.93	Mar 4, 2015	M	42,442	D	—	Dec 15, 2019	Common Stock	42,442	19,431	D
Stock Options (Right to Buy)^F6,F7	$14.93	Mar 5, 2015	M	19,431	D	—	Dec 15, 2019	Common Stock	19,431	0	D
Stock Options (Right to Buy)^F6,F8	$21.64	Mar 5, 2015	M	22,500	D	—	May 26, 2021	Common Stock	22,500	7,500	D

Explanation of responses

F1These shares were acquired upon the exercise of stock options pursuant to a 10b5-1 plan dated September 10, 2014 between the shareholder and Morgan Stanley Smith Barney.
F2These shares are held by The H. Lynn Massingale Trust, of which the Reporting Person is the trustee and sole vested beneficiary.
F3These shares were sold pursuant to a Rule 10b5-1 Trading Plan entered into on September 10, 2014 between H. Lynn Massingale and Morgan Stanley Smith Barney.
F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60 to $60.28, inclusive. The reporting person undertakes to provide to Team Health Holdings, Inc., any security holder of Team Health Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F5The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.17 to $59.82, inclusive. The reporting person undertakes to provide to Team Health Holdings, Inc., any security holder of Team Health Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
F6These stock options were exercised and the option shares were sold pursuant to Rule 10b5-1 Sales Plan dated September 10, 2014 between H. Lynn Massingale and Morgan Stanley Smith Barney, LLC.
F7The stock options are fully vested and excercisable.
F8The stock options are fully vested and exercisable with respect to 75% of the underlying shares and shall vest and become exercisable with respect to the remaining 25% of the underlying shares on the 4th anniversary of the May 26, 2011 grant date.